中文English

Opella Healthcare Group SAS

France · private (CD&R 50.0% controlling, Sanofi 48.2%, Bpifrance 1.8%; closed 2025-04-30) · https://www.aspercreme.com

控制关系图

confirmed: Qunol acquired by Sanofi CHC (closed 2023-09-29); Sanofi CHC = Opella (since 2023-09-29) https://www.sanofi.com/en/media-room/press-releases/2023/2023-07-28-05-32-00-2712870 ; https://hl.com/about-us/transactions/houlihan-lokey-advises-qunol/ ; https://www.opella.com/en/making-headlines/breaking-news/2025-global-opella-independentconfirmed: Opella ANZ brands (Retail Pharmacy, 2025) https://retailpharmacymagazine.com.au/opella-becomes-a-standalone-company/confirmed: Opella ANZ brands (Retail Pharmacy, 2025) https://retailpharmacymagazine.com.au/opella-becomes-a-standalone-company/confirmed: Opella ANZ brands (Retail Pharmacy, 2025) https://retailpharmacymagazine.com.au/opella-becomes-a-standalone-company/confirmed: Qunol acquired by Sanofi CHC (closed 2023-09-29); Sanofi CHC = Opella (since 2023-09-29) https://www.sanofi.com/en/media-room/press-releases/2023/2023-07-28-05-32-00-2712870 ; https://hl.com/about-us/transactions/houlihan-lokey-advises-qunol/ ; https://www.opella.com/en/making-headlines/breaking-news/2025-global-opella-independentconfirmed: Opella press release brand list https://www.opella.com/en/making-headlines/breaking-news/2025-global-opella-independent 公司 Opella Healthcare Group SAS 品牌 Qunol 品牌 Cenovis 品牌 Nature's Own 品牌 Ostelin 品牌 Qunol Plus 品牌 Dulcolax 股东 Clayton, Dubilier & R… 50.0%Sanofi 48.2%Bpifrance 1.8%

实线 = 有来源的已核实关系;虚线 = 未核实。点击方框进入对应公司或品牌。

谁在背后

没有查到上级公司记录。

官方编号

LEI:—

SEC CIK:—

Wikidata:—

数据检查:manual: cited sources 2026-10-26 (groups5) · 更新 2026-10-26

公司概况

公司名称来自品牌官网页脚版权声明(https://www.aspercreme.com),尚未与工商登记或年报核实。

旗下品牌 (13)

Qunol 20 个产品 [来源]

Cenovis 9 个产品 [来源]

Nature's Own 3 个产品 [来源]

Ostelin 2 个产品 [来源]

Qunol Plus 1 个产品 [来源]

Dulcolax 1 个产品 [来源]

Aspercreme 0 个产品 [来源]

Cortizone 10 0 个产品 [来源]

Icy Hot 0 个产品 [来源]

Nasacort 0 个产品 [来源]

Selsun Blue 0 个产品 [来源]

Unisom 0 个产品 [来源]

Xyzal 0 个产品 [来源]

股东

Clayton, Dubilier & Rice (CD&R)50.0%2025-04-30[来源]
Sanofi48.2%2025-04-30[来源]
Bpifrance1.8%2025-04-30[来源]
本站内容只用于了解产品信息,不构成医疗建议。开始或停止任何补剂前,请咨询医生或药师,尤其是孕期、哺乳期、儿童、慢性病患者和正在服药的人。
对比: 0 去对比 → 清除